A brain hemorrhaging patient is not the same as a brain dying patient, and the two can be treated in very different ways, says a professor at Tel Aviv University’s Weizmann Institute of Science.
The term hemorrhagic brain is used by neuroscientists to describe the collapse of the brain’s neurons.
It’s the brain that can’t go on, it’s the blood vessels that stop working and it’s not clear why, he said.
The brain is not only the organ of communication but also the seat of the nervous system.
It controls the body and consciousness.
Hemorrhage is a type of stroke that happens when a blood vessel collapses.
It’s the second-most common cause of stroke in the world, after stroke, he told Army Radio.
The most common type of hemorrhage is known as a stroke in which the blood flow to the brain stops.
A patient’s blood vessel begins to collapse, and there’s no blood flow in the brain.
The blood vessel can’t keep up with the flow of the blood, causing the brain to lose all its nerve impulses.
That’s what happens to people with hemorrhagic stroke.
Hence, it can be extremely painful, and it can leave a brain that’s partially paralyzed.
The loss of brain function can lead to permanent damage, but the brain doesn’t die.
Brain hemorrhage can be caused by a combination of a heart attack, stroke, and brain trauma, but usually the two are the primary causes of stroke, the Weizman Professor said.
But in rare cases, there is a secondary problem with the brain, such as a clot in the skull or blood clots in the cerebrospinal fluid.
A stroke in patients who suffer a brain injury has a different type of brain damage.
A clot in a patient’s brain is caused by blood clumping.
A clot in an area of the head caused by brain injury is caused mainly by a blood clot.
The Weizmans have found that brain hemorrhages are more common in patients with strokes, with strokes occurring in 4% to 6% of patients, he added.
A brain hemorrhagic patient may experience hallucinations and memory loss, as well as confusion, fatigue and loss of consciousness, the professor explained.
When they are in a coma, the brain will also have some problems.
A stroke can lead the patient to go into an “adrenaline rush,” a feeling of exhilaration and fullness, the doctor explained.
This can lead him to forget that he has a stroke, causing him to lose consciousness.
There are many other factors that can cause brain hemorrhaged patients to experience hallucinations, the Professor said, adding that it’s important to take precautions before venturing outside.
The only thing we can do is try to stay alert, avoid contact with people, and monitor them closely, he warned.
Brain bleeding patients also tend to have increased anxiety and depression, which can cause them to become more irritable and aggressive, the neurosurgeon said.
However, he pointed out that there is no such thing as a safe treatment.
If you feel that you need to see a doctor, then it is important that you stay safe and have the necessary equipment, he noted.
It is crucial to stay in good physical condition, and stay away from people with mental health problems, he emphasized.
A person’s mental health is a complex topic that can be affected by many things, the neurologist said.
In order to treat a stroke with the best possible outcome, it is vital to understand how the brain works and what causes it, he stressed.
There is a growing body of research showing that the brain can be damaged and that certain therapies can help.
A new study from Tel Aviv’s Weitzman Institute of Sciences published this week found that certain drugs could help patients recover from hemorrhagic strokes.
The research was led by Prof. Yehuda Stern and his team.
It was published in the prestigious journal Frontiers in Neurosciences.
Dr. Stern said the drug daclizumab was approved in July 2018 and the study has been going on since last September.
The drugs target a protein that controls how the blood clumps.
They are injected into a part of the cerebellum that is responsible for brain function.
The team’s preliminary findings showed that the daclzumab could help people with stroke recover from the stroke and to prevent the development of a new stroke.
The drug is an anti-clotting agent that can also help with the swelling of the stroke patient’s arteries.
The dacluzumab works by reducing blood clump formation, and by blocking the production of proteins that clump.
The researchers found that in a study of the patients’ blood vessels, daclazumab worked better than placebo.
The study also showed that dacliazumab increased the blood volume of the injured brain.
The results are important for the development and testing of a drug that can block the formation of clumps